Resonance Health Limited (ASX:RHT)
0.0400
+0.0030 (8.11%)
Apr 23, 2025, 4:10 PM AEST
Resonance Health Revenue
Resonance Health had revenue of 5.21M AUD in the half year ending December 31, 2024, with 148.10% growth. This brings the company's revenue in the last twelve months to 10.53M, up 89.13% year-over-year. In the fiscal year ending June 30, 2024, Resonance Health had annual revenue of 8.59M with 95.02% growth.
Revenue (ttm)
10.53M
Revenue Growth
+89.13%
P/S Ratio
1.75
Revenue / Employee
658.40K
Employees
16
Market Cap
18.38M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 8.59M | 4.19M | 95.02% |
Jun 30, 2023 | 4.40M | 551.38K | 14.31% |
Jun 30, 2022 | 3.85M | 74.06K | 1.96% |
Jun 30, 2021 | 3.78M | 110.73K | 3.02% |
Jun 30, 2020 | 3.67M | 43.64K | 1.20% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |